| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
Primary Peritonitis
[description not available] | 0 | 2.41 | 2 | 0 |
Peritonitis
INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. | 0 | 2.41 | 2 | 0 |
Breast Cancer
[description not available] | 0 | 2.49 | 2 | 0 |
Breast Neoplasms
Tumors or cancer of the human BREAST. | 0 | 2.49 | 2 | 0 |
Experimental Hepatoma
[description not available] | 0 | 2.06 | 1 | 0 |
Condition, Preneoplastic
[description not available] | 0 | 2.06 | 1 | 0 |
Precancerous Conditions
Pathological conditions that tend eventually to become malignant. | 0 | 2.06 | 1 | 0 |
Hepatocellular Carcinoma
[description not available] | 0 | 2.11 | 1 | 0 |
Innate Inflammatory Response
[description not available] | 0 | 4.3 | 5 | 0 |
Cancer of Liver
[description not available] | 0 | 2.59 | 2 | 0 |
Carcinoma, Hepatocellular
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. | 0 | 2.11 | 1 | 0 |
Inflammation
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. | 0 | 4.3 | 5 | 0 |
Liver Neoplasms
Tumors or cancer of the LIVER. | 0 | 2.59 | 2 | 0 |
Inflammatory Response Syndrome, Systemic
[description not available] | 0 | 2.31 | 1 | 0 |
Cerebral Infarction, Middle Cerebral Artery
[description not available] | 0 | 2.31 | 1 | 0 |
Systemic Inflammatory Response Syndrome
A systemic inflammatory response to a variety of clinical insults, characterized by two or more of the following conditions: (1) fever | 0 | 2.31 | 1 | 0 |
Infarction, Middle Cerebral Artery
NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction. | 0 | 2.31 | 1 | 0 |
Chronic Kidney Diseases
[description not available] | 0 | 6.12 | 7 | 1 |
Acute Kidney Failure
[description not available] | 0 | 3.33 | 1 | 0 |
Renal Insufficiency, Chronic
Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002) | 0 | 6.12 | 7 | 1 |
Acute Kidney Injury
Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. | 0 | 3.33 | 1 | 0 |
Arthritis, Degenerative
[description not available] | 0 | 2.41 | 1 | 0 |
Osteoarthritis
A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. | 0 | 2.41 | 1 | 0 |
Germinoblastoma
[description not available] | 0 | 2.41 | 1 | 0 |
ATLL
[description not available] | 0 | 2.41 | 1 | 0 |
Lymphoma
A general term for various neoplastic diseases of the lymphoid tissue. | 1 | 4.41 | 1 | 0 |
Leukemia-Lymphoma, Adult T-Cell
Aggressive T-Cell malignancy with adult onset, caused by HUMAN T-LYMPHOTROPIC VIRUS 1. It is endemic in Japan, the Caribbean basin, Southeastern United States, Hawaii, and parts of Central and South America and sub-Saharan Africa. | 0 | 2.41 | 1 | 0 |
Endotoxin Shock
[description not available] | 0 | 2.41 | 1 | 0 |
Shock, Septic
Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. | 0 | 2.41 | 1 | 0 |
Atheroma
[description not available] | 0 | 2.41 | 1 | 0 |
Diabetes Mellitus
A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE. | 0 | 3.64 | 2 | 0 |
Malignant Melanoma
[description not available] | 0 | 2.41 | 1 | 0 |
Melanoma
A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) | 0 | 2.41 | 1 | 0 |
Diabetic Glomerulosclerosis
[description not available] | 0 | 5.01 | 6 | 0 |
Diabetic Nephropathies
KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. | 0 | 5.01 | 6 | 0 |
Cell Transformation, Neoplastic
Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. | 0 | 2.82 | 2 | 0 |
Airflow Obstruction, Chronic
[description not available] | 0 | 2.41 | 1 | 0 |
Pulmonary Disease, Chronic Obstructive
A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA. | 0 | 2.41 | 1 | 0 |
Acute-On-Chronic Liver Failure (ACLF)
[description not available] | 0 | 2.41 | 1 | 0 |
Acute-On-Chronic Liver Failure
Sudden liver failure in the presence of underlying compensated chronic LIVER DISEASE (e.g., LIVER CIRRHOSIS; HEPATITIS; and liver injury and failure) due to a precipitating acute hepatic insult. | 0 | 2.41 | 1 | 0 |
Aura
[description not available] | 0 | 2.41 | 1 | 0 |
Epilepsy
A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) | 0 | 2.41 | 1 | 0 |
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. | 0 | 2.41 | 1 | 0 |
Alport Syndrome
[description not available] | 0 | 9.28 | 2 | 1 |
Nephritis, Hereditary
A group of inherited conditions characterized initially by HEMATURIA and slowly progressing to RENAL INSUFFICIENCY. The most common form is the Alport syndrome (hereditary nephritis with HEARING LOSS) which is caused by mutations in genes for TYPE IV COLLAGEN and defective GLOMERULAR BASEMENT MEMBRANE. | 0 | 4.28 | 2 | 1 |
Liver Dysfunction
[description not available] | 0 | 2.41 | 1 | 0 |
Liver Diseases
Pathological processes of the LIVER. | 0 | 2.41 | 1 | 0 |
Injuries, Radiation
[description not available] | 0 | 3.33 | 1 | 0 |
Mucositis, Oral
[description not available] | 0 | 3.33 | 1 | 0 |
Stomatitis
INFLAMMATION of the soft tissues of the MOUTH, such as MUCOSA; PALATE; GINGIVA; and LIP. | 0 | 3.33 | 1 | 0 |
Mucositis
An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY). | 0 | 3.33 | 1 | 0 |
Grippe
[description not available] | 0 | 2.41 | 1 | 0 |
Influenza, Human
An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. | 0 | 2.41 | 1 | 0 |
Kidney Diseases
Pathological processes of the KIDNEY or its component tissues. | 0 | 3.33 | 1 | 0 |
Heritable Pulmonary Arterial Hypertension
[description not available] | 0 | 3.33 | 1 | 0 |
Pulmonary Hypertension
[description not available] | 0 | 3.33 | 1 | 0 |
Pulmonary Arterial Hypertension
A progressive rare pulmonary disease characterized by high blood pressure in the PULMONARY ARTERY. | 0 | 3.33 | 1 | 0 |
Hypertension, Pulmonary
Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. | 0 | 3.33 | 1 | 0 |
Familial Primary Pulmonary Hypertension
Familial or idiopathic hypertension in the PULMONARY CIRCULATION which is not secondary to other disease. | 0 | 3.33 | 1 | 0 |
Benign Neoplasms
[description not available] | 0 | 2.41 | 1 | 0 |
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. | 0 | 2.41 | 1 | 0 |
Adenocarcinoma, Basal Cell
[description not available] | 0 | 2.41 | 1 | 0 |
Cancer of Pancreas
[description not available] | 0 | 3.33 | 4 | 0 |
Adenocarcinoma
A malignant epithelial tumor with a glandular organization. | 0 | 2.41 | 1 | 0 |
Pancreatic Neoplasms
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). | 0 | 3.33 | 4 | 0 |
Autoimmune Disease
[description not available] | 0 | 2.41 | 1 | 0 |
Autoimmune Diseases
Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. | 0 | 2.41 | 1 | 0 |
Uveitis
Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed) | 0 | 2.41 | 1 | 0 |
Cognitive Decline
[description not available] | 0 | 2.41 | 1 | 0 |
Acute Onset Vascular Dementia
[description not available] | 0 | 2.41 | 1 | 0 |
Dementia, Vascular
An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44) | 0 | 2.41 | 1 | 0 |
Cognitive Dysfunction
Diminished or impaired mental and/or intellectual function. | 0 | 2.41 | 1 | 0 |
Cancer of Colon
[description not available] | 0 | 2.41 | 1 | 0 |
Colonic Neoplasms
Tumors or cancer of the COLON. | 0 | 2.41 | 1 | 0 |
Cancer of Skin
[description not available] | 0 | 2.41 | 1 | 0 |
Skin Neoplasms
Tumors or cancer of the SKIN. | 0 | 2.41 | 1 | 0 |
Diabetes Mellitus, Adult-Onset
[description not available] | 0 | 4.4 | 2 | 1 |
Insulin Sensitivity
[description not available] | 0 | 2.6 | 1 | 0 |
Diabetes Mellitus, Type 2
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. | 0 | 4.4 | 2 | 1 |
Insulin Resistance
Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. | 0 | 2.6 | 1 | 0 |
Obesity
A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY). | 0 | 2.6 | 1 | 0 |
Burns
Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like. | 0 | 2.6 | 1 | 0 |
Proteinuria
The presence of proteins in the urine, an indicator of KIDNEY DISEASES. | 0 | 3.99 | 1 | 1 |
Kahler Disease
[description not available] | 0 | 2.6 | 1 | 0 |
Multiple Myeloma
A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. | 0 | 2.6 | 1 | 0 |
Fatty Liver, Nonalcoholic
[description not available] | 0 | 2.6 | 1 | 0 |
Non-alcoholic Fatty Liver Disease
Fatty liver finding without excessive ALCOHOL CONSUMPTION. | 0 | 2.6 | 1 | 0 |